Resveratrol inhibition of human keratinocyte proliferation via SIRT1/ARNT/ERK dependent downregulation of aquaporin 3

Journal of Dermatological Science

Volumn 75, Issue 1, 2014, Pages 16-23

  Wu, Zhouwei ^a,b   Uchi, Hiroshi ^b,c   Morino Koga, Saori ^b   Shi, Weimin ^a   Furue, Masutaka ^b,c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Aquaporin 3; ARNT; ERK; Keratinocytes; Resveratrol; SIRT1

Indexed keywords

AQUAPORIN 3; HYPOXIA INDUCIBLE FACTOR 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RESVERATROL; SIRTUIN 1; SMALL INTERFERING RNA; AQP3 PROTEIN, HUMAN; ARNT PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; SIRT1 PROTEIN, HUMAN; STILBENE DERIVATIVE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; KERATINOCYTE; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN DISEASE; UPREGULATION; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; FIBROBLAST; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHOSPHORYLATION; RNA INTERFERENCE;

AQUAPORIN 3; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; HUMANS; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SIRTUIN 1; STILBENES; TRANSFECTION;

EID: 84901667175     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2014.03.004     Document Type: Article

References (38)

1. Carbrey J.M., Agre P. Discovery of the aquaporins and development of the field. Handb Exp Pharmacol 2009, 190:3-28.
2. Verkman A.S. Aquaporins: translating bench research to human disease. J Exp Biol 2009, 212:1707-1715.
3. Ma T., Hara M., Sougrat R., Verbavatz J.M., Verkman A.S. Impaired stratum corneum hydration in mice lacking epidermal water channel aquaporin-3. J Biol Chem 2002, 277:17147-17153.
4. Hara-Chikuma M., Verkman A.S. Roles of aquaporin-3 in the epidermis. J Invest Dermatol 2008, 128:2145-2151.
5. Nakahigashi K., Kabashima K., Ikoma A., Verkman A.S., Miyachi Y., Hara-Chikuma M. Upregulation of aquaporin-3 is involved in keratinocyte proliferation and epidermal hyperplasia. J Invest Dermatol 2011, 131:865-873.
6. Herbert K.J., Snow E.T. Modulation of arsenic-induced epidermal growth factor receptor pathway signalling by resveratrol. Chem Biol Interact 2012, 198:38-48.
7. Ji C., Cao C., Lu S., Kivlin R., Amaral A., Kouttab N., et al. Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells. Cancer Chemother Pharmacol 2008, 62:857-865.
8. Song X., Xu A., Pan W., Wallin B., Kivlin R., Lu S., et al. Nicotinamide attenuates aquaporin 3 overexpression induced by retinoic acid through inhibition of EGFR/ERK in cultured human skin keratinocytes. Int J Mol Med 2008, 22:229-236.
9. Chan C.M., Chang H.H., Wang V.C., Huang C.L., Hung C.F. Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRbeta, PI3K/Akt and MAPK pathways. PLoS ONE 2013, 8:e56819.
10. Casper R.F., Quesne M., Rogers I.M., Shirota T., Jolivet A., Milgrom E., et al. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol 1999, 56:784-790.
11. Beischlag T.V., Luis Morales J., Hollingshead B.D., Perdew G.H. The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr 2008, 18:207-250.
12. Wenger R.H., Gassmann M. Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 1997, 378:609-616.
13. Chen S., Operana T., Bonzo J., Nguyen N., Tukey R.H. ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: implications for transcriptional activation and protein degradation. J Biol Chem 2005, 280:4350-4359.
14. Singh N.P., Singh U.P., Hegde V.L., Guan H., Hofseth L., Nagarkatti M., et al. Resveratrol (trans-3,5,4'-trihydroxystilbene) suppresses EL4 tumor growth by induction of apoptosis involving reciprocal regulation of SIRT1 and NF-kappaB. Mol Nutr Food Res 2011, 55:1207-1218.
15. Blander G., Bhimavarapu A., Mammone T., Maes D., Elliston K., Reich C., et al. SIRT1 promotes differentiation of normal human keratinocytes. J Invest Dermatol 2009, 129:41-49.
16. Holian O., Walter R.J. Resveratrol inhibits the proliferation of normal human keratinocytes in vitro. J Cell Biochem Suppl Suppl 2001, 36:55-62.
17. Fouad M., Agha A., Merzabani M.A., Shouman S. Resveratrol inhibits proliferation, angiogenesis and induces apoptosis in colon cancer cells: calorie restriction is the force to the cytotoxicity. Hum Exp Toxicol 2013, 32:1067-1080.
18. Rudzitis-Auth J., Menger M.D., Laschke M.W. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis. Hum Reprod 2013, 28:1339-1347.
19. Hara-Chikuma M., Verkman A.S. Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing. J Mol Med (Berl) 2008, 86:221-231.
20. Cao C., Sun Y., Healey S., Bi Z., Hu G., Wan S., et al. EGFR-mediated expression of aquaporin-3 is involved in human skin fibroblast migration. Biochem J 2006, 400:225-234.
21. Robertson E.D., Weir L., Romanowska M., Leigh I.M., Panteleyev A.A. ARNT controls the expression of epidermal differentiation genes through HDAC- and EGFR-dependent pathways. J Cell Sci 2012, 125:3320-3332.
22. Sutter C.H., Yin H., Li Y., Mammen J.S., Bodreddigari S., Stevens G., et al. EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes. Proc Natl Acad Sci USA 2009, 106:4266-4271.
23. Chou W.W., Chen K.C., Wang Y.S., Wang J.Y., Liang C.L., Juo S.H. The role of SIRT1/AKT/ERK pathway in ultraviolet B induced damage on human retinal pigment epithelial cells. Toxicol In Vitro 2013, 27:1728-1736.
24. Cao L., Liu H., Lam D.S., Yam G.H., Pang C.P. In vitro screening for angiostatic potential of herbal chemicals. Invest Ophthalmol Vis Sci 2010, 51:6658-6664.
25. Hara-Chikuma M., Verkman A.S. Aquaporin-3 functions as a glycerol transporter in mammalian skin. Biol Cell 2005, 97:479-486.
26. Sougrat R., Morand M., Gondran C., Barré P., Gobin R., Bonté F., et al. Functional expression of AQP3 in human skin epidermis and reconstructed epidermis. J Invest Dermatol 2002, 118:678-685.
27. Voss K.E., Bollag R.J., Fussell N., By C., Sheehan D.J., Bollag W.B. Abnormal aquaporin-3 protein expression in hyperproliferative skin disorders. Arch Dermatol Res 2011, 303:591-600.
28. Zhang X., Wang Y., Yang W., Hou X., Zou J., Cao K. Resveratrol inhibits angiotensin II-induced ERK1/2 activation by downregulating quinone reductase 2 in rat vascular smooth muscle cells. J Biomed Res 2012, 26:103-109.
29. Liang Y., Li W.W., Yang B.W., Tao Z.H., Sun H.C., Wang L., et al. Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma. Int J Cancer 2012, 130:1745-1754.
30. Potapovich A.I., Lulli D., Fidanza P., Kostyuk V.A., De Luca C., Pastore S., et al. Plant polyphenols differentially modulate inflammatory responses of human keratinocytes by interfering with activation of transcription factors NFkappaB and AhR and EGFR-ERK pathway. Toxicol Appl Pharmacol 2011, 255:138-149.
31. Denison M.S., Soshilov A.A., He G., DeGroot D.E., Zhao B. Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol Sci 2011, 124:1-22.
32. Mohammadi-Bardbori A., Bengtsson J., Rannug U., Rannug A., Wincent E. Quercetin, resveratrol, and curcumin are indirect activators of the aryl hydrocarbon receptor (AHR). Chem Res Toxicol 2012, 25:1878-1884.
33. Sogawa K., Nakano R., Kobayashi A., Kikuchi Y., Ohe N., Matsushita N., et al. Possible function of Ah receptor nuclear translocator (Arnt) homodimer in transcriptional regulation. Proc Natl Acad Sci USA 1995, 92:1936-1940.
34. Swanson H.I., Yang J.H. Specificity of DNA binding of the c-Myc/Max and ARNT/ARNT dimers at the CACGTG recognition site. Nucleic Acids Res 1999, 27:3205-3212.
35. Kozak K.R., Abbott B., Hankinson O. ARNT-deficient mice and placental differentiation. Dev Biol 1997, 191:297-305.
36. Maltepe E., Schmidt J.V., Baunoch D., Bradfield C.A., Simon M.C. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997, 386:403-407.
37. Jeong K.J., Cho K.H., Panupinthu N., Kim H., Kang J., Park C.G., et al. EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: inhibition by resveratrol. Mol Oncol 2013, 7:121-129.
38. Haigis M.C., Guarente L.P. Mammalian sirtuins - emerging roles in physiology, aging, and calorie restriction. Genes Dev 2006, 20:2913-2921.